07670621 is referenced by 1 patents and cites 19 patents.

The invention relates to a device for transdermally administering a compound of formula (I), wherein A represents hydrogen or deuterium, R represents a group selected among C1-4alkyl, C3-10cycloalkyl, or phenyl, each of which can be substituted by C1-3alkoxy, fluoride, chlorine, bromine, iodine, nitro, amino, hydroxy, oxo, mercapto, or deuterium, the C atom marked by * (asterisk) being provided in the R configuration. The invention is characterized in that the compound of general formula (I) is provided in a polymer matrix and is released at a dose of 0.5 to 20 mg per day through human skin. The invention further relates to the use of said compounds of formula (I) for producing transdermal medicaments.

Title
Transdermal administration of (R)-3,3-diphenylpropylamin-monoesters
Application Number
10/533683
Publication Number
7670621 (B2)
Application Date
April 3, 2004
Publication Date
March 2, 2010
Inventor
Roland Drews
Monheim
DE
Hans Michael Wolff
Monheim
DE
Claus Meese
Monheim
DE
Armin Breitenbach
Monheim
DE
Agent
Kenyon & Kenyon
Assignee
Schwarz Pharma
DE
IPC
A61K 9/14
View Original Source